Gamida Cell vs Upstream Bio
Gamida Cell vs Upstream Bio, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Gamida Cell is on 51/100 and Upstream Bio on 61/100.
Where each one leads
Gamida Cell
- domain rating: 40/100 against 32/100
Upstream Bio
- our overall score: 61/100 against 51/100
- funding raised: $400M against $297M
At a glance
| Measure | Gamida Cell | Upstream Bio |
|---|---|---|
| What it is | Biotechnology company developing potentially curative cell therapies for cancer patients. | Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases. |
| Category | Life Sciences, Biotech, MedTech, HealthTech | Life Sciences, Therapeutics, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 1998 | 2021 |
| Headquarters | Boston, United States | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Gamida Cell | Upstream Bio |
|---|---|---|
| Employees | Not published | 75 |
| Headcount growthLast 12 months | Not published | +43.4% |
| Total funding | $297M | $400M |
| Latest round | Post-IPO | Series B |
| Valuation | $160M | Not published |
| LinkedIn followers | Not published | 11,799 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Gamida Cell | Upstream Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 61/100 |
| Traction | 40/100 | 59/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 8/100 | 37/100 |
| Quality | 65/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Gamida Cell | Upstream Bio |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery, Bootstrap |
| Analytics | Google Analytics 4 | Google Tag Manager |
Gamida Cell vs Upstream Bio: common questions
Which is better, Gamida Cell or Upstream Bio?
On our 0-100 score Upstream Bio rates higher (61/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Gamida Cell and Upstream Bio compare on the numbers?
Gamida Cell leads on domain rating (40/100 against 32/100). Upstream Bio leads on our overall score (61/100 against 51/100), funding raised ($400M against $297M).
Read the full Gamida Cell review and pricing or the Upstream Bio review and pricing. You can also browse other Gamida Cell alternatives we track.